順從療法有限公司
US ˙ NasdaqGS ˙ US7291391057

SecurityPLRX / Pliant Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership23,118 shares
Latest Disclosed Value $ 26,816
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 75.44% decrease in ownership of PLRX / Pliant Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 23,118 shares of Pliant Therapeutics, Inc. (US:PLRX) valued at $26,817 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 94,130 shares of Pliant Therapeutics, Inc.. This represents a change in shares of -75.44% during the quarter. The current value of the position is $26,586 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Pliant Therapeutics EC US7291391057 23,118 -71,012 -75.44 27 -79.53 0.0006
2025-05-28 2025-03-31 NP Pliant Therapeutics EC US7291391057 94,130 -4,195 -4.27 127 -90.19 0.0030
2025-02-25 2024-12-31 NP Pliant Therapeutics EC US7291391057 98,325 -15,289 -13.46 1,295 1.65 0.0283
2024-11-26 2024-09-30 NP Pliant Therapeutics EC US7291391057 113,614 7,089 6.65 1,274 11.18 0.0241
2024-08-26 2024-06-30 NP Pliant Therapeutics EC US7291391057 106,525 6,219 6.20 1,145 -23.36 0.0233
2024-05-28 2024-03-31 NP Pliant Therapeutics EC US7291391057 100,306 -2,716 -2.64 1,495 -19.89 0.0312
2024-02-26 2023-12-31 NP Pliant Therapeutics EC US7291391057 103,022 6,642 6.89 1,866 11.61 0.0398
2023-11-28 2023-09-30 NP Pliant Therapeutics EC US7291391057 96,380 -1,105 -1.13 1,671 -5.38 0.0436
2023-08-25 2023-06-30 NP Pliant Therapeutics EC US7291391057 97,485 59,041 153.58 1,766 556.51 0.0419
2022-05-26 2022-03-31 NP Pliant Therapeutics EC US7291391057 38,444 0 0.00 269 -48.07 0.0063
2022-02-25 2021-12-31 NP Pliant Therapeutics EC US7291391057 38,444 0 0.00 519 -20.06 0.0113
2021-11-24 2021-09-30 NP Pliant Therapeutics EC US7291391057 38,444 0 0.00 649 -42.09 0.0143
2021-08-26 2021-06-30 NP Pliant Therapeutics EC US7291391057 38,444 4,674 13.84 1,119 -15.74 0.0240
2021-05-27 2021-03-31 NP Pliant Therapeutics EC US7291391057 33,770 18,150 116.20 1,328 275.14 0.0301
2021-02-25 2020-12-31 NP Pliant Therapeutics EC US7291391057 15,620 0 0.00 355 0.28 0.0091
2020-11-25 2020-09-30 NP Pliant Therapeutics EC US7291391057 15,620 15,620 354 0.0114
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.